A phase 3 trial of pharmaceutical giant Pfizer's newly developed antibiotic combination revealed positive results, revealing a promising treatment for superbug infections, according to a June 1 press release.

The National Institutes of Health's cancer unit is launching the largest study to test combinations of cancer drugs in comparison to the drugs on their own, the organization said June 1. 

After CMS announced plans to preserve availability of Alzheimer's drugs, the Alzheimer's Association has issued a statement in opposition of it.

University of Florida Health's specialty pharmacy recently expanded its list of medications and accepted insurance plans. 

As the U.S. experiences the highest number of drug shortages in 10 years, the FDA and the American Society of Health-System Pharmacists reported 17 new shortages in May. 

The FDA approved the second respiratory syncytial virus vaccine for adults 60 and older on May 31. 

Berberine, a supplement made from plants, is gaining popularity across social media and online searches as a possible alternative to the expensive, prescription-only drugs like Ozempic and Mounjaro, NBC News reports.

Mark Cuban Cost Plus Drug Co. announced that beginning in July it will sell a branded Humira biosimilar known as Yusimry. It is the first biologic product offered by the company.

Colorado acting Gov. Dianne Primavera signed legislation May 30 that bans using the body mass index when determining care for eating disorder patients and prohibits the sale of diet pills to people under 18. 

Johnson & Johnson-owned Janssen Pharmaceuticals has submitted an application to the FDA for approval of what would be the first tablet therapy for patients with pulmonary arterial hypertension. 

Drug prices are rising faster than inflation, according to a new report from the American Hospital Association.

The FDA proposed a new, one-page medication guide outline for prescription drugs and biologics to ensure a "consistent and easy-to-understand format" for patients, the agency said May 30. 

There's a case for EDs to dispense medications as the U.S. tracks low medication adherence after emergency visits, according to an American Academy of Pediatrics study published May 30. 

Health experts are hoping the next altered COVID-19 vaccine will return to being monovalent but focus solely on XBB.1, The Atlantic reported May 26. 

An ongoing shortage of cancer drug cisplatin just got longer. 

Patient safety is often viewed from a lens inside medical center and hospital walls, but the leadership of pharmacists and decisions made along the medical supply chain also play a role, Londa Ritchey, the quality director at PharmaLex wrote in a May 25 article for PharmaPhorum.

The ongoing amoxicillin shortage is projected to continue into June, according to a May 22 update from the American Society of Health-System Pharmacists.

PTC Therapeutics, a drug development company based in South Plainfield, N.J., said it will lay off 94 employees at its corporate office by Aug. 21, according to a notice filed in the state. 

The FDA granted Pfizer's popular COVID-19 antiviral treatment, Paxlovid, full approval on May 25.

Some hospitals are scraping vials to offer enough cancer drugs for their patients as the U.S. faces about two dozen chemotherapy shortages.